Bioretec Ltd  Company announcement      15 March 2024 at 5:30 p.m. EET
 

Bioretec Ltd has today published its 2023 Annual Report, Financial Statements and Report by the Board of Directors. The publications are attached to this release and also available in Finnish and English on the company's website at www.bioretec.com/investors/investors-in-english/reports-and-presentations.

 

Further enquiries

Timo Lehtonen, CEO, +358 50 433 8493
Johanna Salko, CFO, +358 40 754 8172
 

Certified adviser

Nordic Certified Adviser AB, +46 70 551 67 29

 

Bioretec in brief

Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries. 

Bioretec is developing the new RemeOs(TM) product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs(TM) implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on value for patients through efficient healthcare. The first RemeOs(TM) product market authorization has been received in the U.S. in March 2023, and in Europe, CE mark is expected to be received during the second quarter of 2024. Bioretec is positioning itself to enter the addressable over USD 7 billion global orthopedic trauma market and to become a game changer in surgical bone fracture treatment.

 

Better healing - Better life. www.bioretec.com

 

https://news.cision.com/bioretec/r/bioretec-ltd-s-annual-report-and-financial-statements-2023-published,c3946950

https://mb.cision.com/Main/20509/3946950/2673900.pdf

https://mb.cision.com/Public/20509/3946950/89df36a5327888dd.pdf

(c) 2024 Cision. All rights reserved., source Press Releases - English